Back to top
more

ProShares S&P 500 Dividend Aristocrats ETF: (NOBL)

(Delayed Data from NYSE MKT (ex. AMEX)) As of Feb 27, 2026 04:00 PM ET

$114.49 USD

114.4873
601,633

+0.65 (0.57%)

Volume: 601,633

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $114.59 +0.10 (0.09 %) 7:58 PM ET

Zacks News

Santanu Roy  headshot

Beat the Market the Zacks Way: Micron Technology, Cooper Companies, Coeur Mining in Focus

Micron Technology surges 66.8% in 12 weeks as Zacks spotlights standout picks beating a volatile market despite tech selloff.

Santanu Roy  headshot

Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus

Starbucks delivered 15.6% gains in 12 weeks as Zacks portfolios highlighted standout stock winners amid volatile markets.

Zacks Equity Research

Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?

Smart Beta ETF report for NOBL

Santanu Roy  headshot

Take the Zacks Approach to Beat the Markets: Indivior, FIGS & Ulta Beauty in Focus

Zacks highlights how Indivior, FIGS and Ulta Beauty delivered outsized gains as its ranks, recommendations and focus lists beat a volatile market.

Santanu Roy  headshot

Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus

Castle Biosciences surged 77.9% after a Zacks upgrade, highlighting how the firm's stock picks outpaced the broader market in recent months.

Santanu Roy  headshot

Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus

Liquidia shares have surged 43.9% since an October upgrade, as Zacks highlights stock wins and portfolio results despite a volatile market.

Santanu Roy  headshot

Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus

MBX Biosciences' sharp rally highlights how Zacks' stock recommendations outpaced broader market gains across multiple portfolios.

Santanu Roy  headshot

Take the Zacks Approach to Beat the Markets: Macy's, United Natural Foods & Monster Beverage in Focus

Macy's climbs after a Zacks upgrade as multiple portfolios showcase strong gains across UNFI, Monster Beverage and other standout stocks.

Sanghamitra Saha headshot

Buffett's Investing Lessons: What They Mean for ETF Investors

Buffett's final lessons guide ETF investors toward discipline, cash strength and quality picks like SPY, ITOT, VTV and MINT.

Zacks Equity Research

Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?

Smart Beta ETF report for NOBL